Background Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions ...

Cardiovascular complications are increasingly recognised as a major driver of morbidity and early mortality in patients with sickle cell disease (SCD), yet they remain underdiagnosed and ...

Diastolic dysfunction has a major impact on symptom status, functional capacity, medical treatment, and prognosis in both systolic and diastolic heart failure (HF), irrespective of the cause.w1 w2 ...

The estimate put to the House of Commons Health Select Committee was that 25 000 people in the UK die from preventable hospital-acquired venous thromboembolism (VTE) every year.1 In addition to those ...

Atrial septal aneurysm is an uncommon condition. Between 1981 and 1984 10 cases of atrial septal aneurysm were diagnosed by real time cross sectional echocardiography performed in 4840 patients. The ...

Infective endocarditis is a rare condition with an incidence of less than 10 per 100 000 population/year. It is, however, associated with a high mortality and morbidity. Accepted clinical practice has ...

Congenitally corrected transposition of the great arteries (ccTGA) is a rare defect representing approximately 0.5% of all congenital heart disease. ccTGA is characterised by the combination of ...

The workup of cardiac disease in patients with autoimmune disorders The range of CV manifestations of rheumatological diseases are broad and include but are not restricted to coronary artery disease ...

The ‘Fontan circulation' has evolved to include a variety of surgical procedures designed to overcome the absence of two distinct ventricular chambers.1 w1–w3 Inherent to this circulation is chronic ...

OBJECTIVE--To evaluate the incidence, characteristics, and haemodynamic consequences of pericardial effusion after cardiac surgery. DESIGN--Clinical, echocardiographic, and Doppler evaluations before ...

Objectives Most patients with hypertension require more than one drug to attain recommended blood pressure (BP) targets. Initiating therapy with two agents is recommended for patients at high risk of ...